who-istock-481275412

godfather744431 / iStockphoto.com

18 March 2019Americas

WHO and UN actions undermine IP and hurt innovation, warns PhRMA

Supranational organisations such as the World Health Organization (WHO) and the United Nations Development Program (UNDP) are promoting acts, policies and practices that prevent biopharmaceutical innovators from securing and maintaining patents.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

20 February 2018 Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”.

PhRMA urges USTR to protect US innovation abroad

13 February 2017 The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.

More on this story

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

20 February 2018 Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”.

PhRMA urges USTR to protect US innovation abroad

13 February 2017 The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.

More on this story

Biotech groups slam Malaysia, Canada and Korea in Special 301 comments

20 February 2018 Trade associations Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization have called for Malaysia to be placed on the US Trade Representative’s watch list in its “2018 Special 301 Report”.

PhRMA urges USTR to protect US innovation abroad

13 February 2017 The Pharmaceutical Research and Manufacturers of America has urged the US Trade Representative to protect US innovators abroad.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?